Journal
NUCLEUS
Volume 2, Issue 4, Pages 300-309Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/nucl.2.4.16767
Keywords
chromatin plasticity; embryonic stem cells; histone acetylation; histone modifications
Categories
Funding
- Eunice Kennedy Shriver National Institute of Child Health and Human Development/NIH/HHS
- Israel Science Foundation [215/07, 943/09]
- Israel Ministry of Health [6007]
- EU [IRG-206872, 238176]
- ICRF
- HUJI
- Israeli Psychobiology Institute
- Alon Fellowship
Ask authors/readers for more resources
The pluripotent genome is characterized by unique epigenetic features and a decondensed chromatin conformation. However, the relationship between epigenetic regulation and pluripotency is not altogether clear. Here, using an enhanced MEF/ESC fusion protocol, we compared the reprogramming potency and histone modifications of different embryonic stem cell (ESC) lines (R1, J1, E14, C57BL/6) and found that E14 ESCs are significantly less potent, with significantly reduced H3K9ac levels. Treatment of E14 ESCs with histone deacetylase (HDAC) inhibitors (HDACi) increased H3K9ac levels and restored their reprogramming capacity. Microarray and H3K9ac ChIP-seq analyses, suggested increased extracellular matrix (ECM) activity following HDACi treatment in E14 ESCs. These data suggest that H3K9ac may predict pluripotency and that increasing pluripotency by HDAC inhibition acts through H3K9ac to enhance the activity of target genes involved in ECM production to support pluripotency.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available